Skip to content
Information Technology, Medical Health Aged Care

Australian-first data partnership to supercharge immune health research

Snow Centre for Immune Health 3 mins read

An Australian-first data partnership has set a new benchmark for medical research, with the establishment of a next-generation digital platform that aims to fast-track breakthroughs in immune health research.

 

The landmark partnership between the Snow Centre for Immune Health - co led by WEHI and the Royal Melbourne Hospital (RMH) in partnership with Snow Medical Research Foundation - and BioGrid Australia is an Australian-first collaboration bringing together clinicians and researchers, supported by the Aridhia Digital Research Environment (DRE), a secure, cloud-based platform.

 

The Aridhia DRE is changing the way clinical and research professionals work together – enabling Australian researchers to work seamlessly with national and international partners in real time.

 

This innovative, purpose-built research environment provides secure storage to easily access, share and analyse research and clinical data obtained from study patients in an integrated manner.

Breaking down data silos


Co-led by WEHI and the RMH, in partnership with Snow Medical Research Foundation, the Snow Centre is spearheading a bold new approach to immune system research, tackling diseases that affect millions of Australians.

This partnership will enable researchers to securely access and collaborate on patient samples, such as blood and saliva, and associated research data – all from a single, secure hub.

 

Dr Paul Lyons, Snow Centre Chief Consulting Scientist, said: “This partnership gives us the tools to tackle some of the most complex and devastating immune diseases with a truly integrated approach.

 

“Easy access to data via this secure digital platform will enable our researchers to deliver transformational impacts for patients. This isn’t just technology – it’s a tool for change.”

 

Created by researchers for researchers, BioGrid has spent the past two decades serving the needs of Australia’s medical research community.

 

BioGrid will provide the platform to securely house the data and support the Snow Centre with the ethics and governance framework needed to facilitate responsible, compliant data sharing, enabling faster implementation of programs for researchers and protecting patient privacy.

 

Maureen Turner, CEO of BioGrid Australia, said: “BioGrid will remove long-standing barriers to data access and collaboration, through easy access to the Aridhia DRE platform. We’re enabling researchers to work faster and smarter.”

 

Next-generation research environment

 

Aridhia’s industry leading research environment offers support for a wide variety of multi-modal data types including clinical data from Electronic Medical Records (EMR), medical imaging, and genomic data using common data models like OMOP and SDTM.

 

It empowers data owners to create secure access to their data collections by research teams through the ISO 27001, ISO 27701 and HITRUST certified platform.

 

It has a rich metadata catalog, configurable data governance, private, airlocked collaboration workspaces and built-in analytics tools to easily explore data and build and share a cohort without writing code.

 

Researchers and clinicians can now securely access and collaborate with national and international partners. As the scope of the Snow Centre’s work with collaborators grows, this will be particularly beneficial to this globally focused work.

 

Fast tracking results

 

The Snow Centre takes a whole of person approach to immune health research. The new platform will support the Snow Centre's goals to deliver earlier diagnoses, better treatments and improved outcomes for patients living with debilitating immune conditions.

 

“This is about accelerating answers for patients,” Dr Lyons said. “This landmark partnership accelerates our ability to move from research to real-world impact.”


Key Facts:

An Australian first partnership between the Snow Centre for Immune Health and BioGrid Australia to fast-track immune health research via a secure, cloud-based platform.

The Aridhia DRE supports global collaborations by allowing Australian researchers to effortlessly work with global partners in real time.

The Aridhia DRE platform is ISO 27001 Information Security Management certified, ISO 27701 GDPR Privacy Information Management certified, and HITRUST certified, providing the highest levels of data security and privacy protection.


About us:

The Snow Centre for Immune Health is tackling the major global health challenge of immune health.

The centre has a bold and ambitious global mission to improve the lives of people with immune diseases, using a unique approach to immune health.

Co-led by WEHI and the Royal Melbourne Hospital (RMH), in partnership with the Snow Medical Research Foundation, the Snow Centre brings together leading Australian and international researchers with a shared mission to transform how we research and treat the immune system.

The centre is funded by an initial commitment of up to $100 million over 10 years – one of the largest and longest-running philanthropic partnerships in Australian history.

To find out more, visit snowimmunehealth.org.au 


Contact details:

Snow Centre for Immune Health
Inga Feitsma, Marketing and Communications Manager, Snow Centre for Immune Health
M: +61 408 657 741
E: [email protected] 

BioGrid Australia
Anita Coia, Communications Specialist, BioGrid Australia
M: +61 419 550 893
E: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 10/02/2026
  • 19:26
Takeda Pharmaceutical Company Limited

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin…

  • Contains:
  • Medical Health Aged Care
  • 10/02/2026
  • 16:32
Dementia Australia

Release of Framework for National Dementia Action Plan welcome but further investment is urgently needed

Dementia Australia welcomes the release of the Collective Priority Framework for the National Dementia Action Plan, but says further investment is urgently needed to address the growing impact of dementia in Australia. The Commonwealth and all state and territory Health Ministers have agreed the urgent priorities for action are: Empowering individuals and communities to minimise risk where they can, and delay onset and progression. Improving dementia diagnosis and post-diagnostic care and support. Improve dementia data, maximise the impact of dementia research and promote innovation. Dementia Australia CEO Professor Tanya Buchanan said the release of the framework is a positive development…

  • Medical Health Aged Care
  • 10/02/2026
  • 14:38
Palliative Care Australia

Palliative Care Australia backs calls to end placement poverty for medical and allied health students

Palliative Care Australia (PCA) supports calls to expand the CommonwealthPracPayment to include medical and allied health students, following the release of Parliamentary Budget Office costings commissioned by independent MP Dr Helen Haines and independent Senator David Pocock. The costingsindicatethe expansion would cost $290 million over the four years of the forward estimates. PCA National Policy Director Josh Fear said reducing financial hardship during placements isan important stepfor building the health workforce Australians rely on, including palliative care services. “Palliative care is delivered by multidisciplinary teams, and we need a strong pipeline of medical and allied health professionals to meet community…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.